Comparative Studies in the Promoter and Exon 1 Regions of Tumour Suppressor p53 in Several Mammalian Species: Absence of Mutations in a Panel of Spontaneous Domestic Animal Tumours

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 47, Issue 10, 2000, Pages 593-597

  Mayr, B ^a   Resch, S ^a   Hepperle, S ^a   Brem, G ^a   Reifinger, M ^a   Schaffner, G ^b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BOS TAURUS; BOVINAE; CANIS FAMILIARIS; CRICETINAE; EQUIDAE; EQUUS CABALLUS; FELIDAE; FELIS CATUS; MAMMALIA; RODENTIA;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CATTLE; COMPARATIVE STUDY; DNA SEQUENCE; DOG; DOMESTIC ANIMAL; EXON; GENETICS; HORSE; HUMAN; MUTATION; NEOPLASM; PROMOTER REGION; RODENT; SPECIES DIFFERENCE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANIMALS, DOMESTIC; CATS; CATTLE; DOGS; EXONS; GENES, P53; HORSES; HUMANS; MUTATION; NEOPLASMS; PROMOTER REGIONS (GENETICS); RODENTIA; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY;

EID: 0034565620     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.2000.00322.x     Document Type: Article

References (20)

1. Bienz-Tadmor, B., R. Zakut-Henri, S. Libresco, D. Givol, and M. Oren, 1985: The 5′ region of the p53 gene: evolutionary conservation evidence for a negative regulatory element. EMBO J. 14, 3209-3213.
2. Buchman, V. L., P. M. Chumakov, N. N. Ninkina, O. P. Samarina, and G. P. Georgiev, 1988: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70, 245-252.
3. Chumakov, P. M., 1998: The role of p53 gene in programmed cell death. Izv. Akad. Nauk. Ser. Biol. 2, 151-156.
4. Cooper, G. M., 1995: Tumor suppressor genes in human neoplasms. In: Cooper, G. M. (ed.), Oncogenes, 2nd edn, pp. 145-150. Jones & Bartlett Publishing Intern., Sudbury, MA.
5. Dequiedt, F., R. Kettmann, A. Burny, and L. Willems, 1995: Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep. Virology 209, 676-683.
6. Greenblatt, M. S., W. P. Bennett, M. Hollstein, and C. C. Harris, 1994: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
7. Hainaut, P., T. Hernadez, A. Robinson, P. Rodriguez-Tome, T. Flores, M. Hollstein, C. C. Harris, and R. Montesano, 1998: IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucl. Acids Res. 25, 205-213.
8. Levine, A. J., M. E. Perry, A. Chang, A. Silver, D. Dittmer, M. Wu, and D. Welsh, 1994: Walter Hubert Lecture. The role of the p53 tumor suppressor gene in tumorigenesis. Br. J. Cancer 69, 409-416.
9. Mayr, B., U. Heczko, K. Schellander, W. Schleger, and M. Reifinger, 1993: Sequence of an exon of the feline p53 gene-mutation in a lymphosarcoma. Br. Vet. J. 149, 387-390.
10. Mayr, B., M. Reifinger, and K. Alton, 1999: Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms. Vet. Res. Comm. 23, 285-291.
11. Mayr, J. Blauensteiner, A. Edlinger, M. Reifinger, K. Alton, G. Schaffner, and B. G. Brem, 2000: Presence of p53 mutations in feline neoplasms. Res. Vet. Sci. 68, 63-69.
12. Müllenbach, J. P., L. Lagoda, and C. Welter, 1989: An efficient salt-chloroform extraction of DNA blood and tissues. Trends Genet. 5, 391.
13. Nayak, B. K., and B. R. Das, 1999: Mutation and methylation status of p53 gene promoter in human breast tumours. Tumour Biol. 20, 241-346.
14. Okuda, M., A. Umeda, T. Sakai, T. Ohashi, Y. Momoi, H. Y. Youn, T. Watari, R. Goitsuka, H. Tsujimoto, and A. Hasegawa, 1994: Cloning of feline p53 tumor suppressor gene and its aberration in hematopoietic tumor. Intern. J. Cancer 58, 602-607.
15. Pazzi, K. A., S. A. Kraegel, S. M. Griffey, A. P. Theon, and B. R. Madewell, 1996: Analysis of the equine tumor suppressor gene p53 in the normal horse and in eight cutaneous squamous cell carcinoma. Cancer Lett. 107, 125-130.
16. Reisman, D., N. B. Elind, B. Roy, J. Beamon, and V. Rotter, 1993: c-myc transactivates the p53 promoter through a required downstream CACGTG motiv. Cell Growth Differ. 4, 57-65.
17. Reisman, D., and W. Troy Loging, 1998: Transcriptional regulation of the p53 tumor suppressor gene. Cancer Biol. 8, 317-324.
18. Tuck, S. P., and L. Crawford, 1989: Characterization of the human p53 gene promoter. Mol. Cell. Biol. 9, 2163-2172.
19. Van Leeuwen, I. S., C. J. Cornelisse, W. Misdorp, S. A. Goedegebuure, J. Kirpensteijn, and G. R. Rutteman, 1996: p53 gene mutations in osteosarcomas in the dog. Cancer Lett. 111, 173-178.
20. Veldhoen, N., J. Stewart, R. Brown, and J. Milner, 1998: Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene 16, 249-255.